Anti-Vascular Endothelial Growth Factor Therapeutics Market Worth $12.82 Billion By 2028
Anti-Vascular Endothelial Growth Factor Therapeutics Industry Overview The global anti-vascular endothelial growth factor therapeutics market size is expected to reach USD 12.82 billion by 2028, registering a CAGR of 0.5% over the forecast period, according to a new report by Grand View Research, Inc. Increased funding for R&D of anti-VEGF therapeutics to boost the development of new drugs is expected to accelerate market growth. Moreover, the introduction of novel innovative products coupled with the increasing geriatric population that is susceptible to develop ophthalmic diseases is expected to propel the market growth over the forecast period. Anti-Vascular Endothelial Growth Factor Therapeutics Market Segmentation Grand View Research has segmented the global Anti-Vascular Endothelial Growth Factor Therapeutics Market on the basis of products, disease, and region: Based on the Product Insights, the market is segmented into Eylea, Lucentis, Beovu. The ...